| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |